A Clinical Investigation to Assess the Effectiveness of Benzocaine in NRL Condoms in Healthy Adult Men Who Feel They Ejaculate Too Quickly During Vaginal Sex

Main Inclusion Criteria:

• Subjects and their female partners have provided written informed consent.
• Subjects and their female partners between the ages of >= 18 years and =< 60 years.
• Subjects and their female partners must have no health condition in their medical history.
• Subject must be sexually active having regular intercourse.
• Subjects in a stable, monogamous, sexual relationship with the same female partner for more than or equal to 3 months.
• Subject's female partner should already be on an established other highly effective form of non-barrier contraception, unless post-menopausal.
• Subjects reporting a frequency of 'occasionally' to the Sexual Intercourse Self-Estimation Scale.

Main Exclusion Criteria:

• Subject with a pregnant or breastfeeding female partner or the female partner desires to become pregnant during the clinical investigation.
• Subject or his female partner with a current history of alcohol or drug abuse.
• Subjects and their female partners with a history of or are suffering from anemia, coronary artery disease, impaired cardiac conduction, pulmonary disease, diabetes, and renal or hepatic disease.
• Subjects and their female partners with a history of, suspected to have, or be at increased risk of methaemoglobinemia / complications related to ester anaesthetics which could trigger methemoglobinemia.
• Subject and/or his female partner have a physical or psychological condition that would prevent them from following investigation procedures - including but not limited to the following:
• urological disease,
• ongoing significant psychiatric disorder not controlled by medication
• history of surgery or injury to the pelvis, retroperitoneal surgery, radiotherapy, multiple sclerosis, spinal cord injury, chronic inflammation of the prostate or urethra
• relevant previous or planned genital surgery
• female partner that has been diagnosed with or treated for vaginal complaints (including vaginal dryness)
• any broken skin or wounds in the genital area.
• Subjects on medication that is contraindicated, which may affect erection.
• Subject and/or his female partner have any medication which may affect the safety of the subject, including but not limited to benzocaine drug interactions such as cholinesterase inhibitors.
• Subject and/or his female partner is using or intends to continue to use antibiotics of the sulphonamide type.
• Subject with premature ejaculation, erectile dysfunction, hypo or hyperthyroidism, hypogonadism, hyperprolactinemia, ejaculatory dysfunction, haemorrhagic disorder, hepatitis B or C, human immunodeficiency virus (HIV) infection or having had penile implant surgery.
• Subject that has been diagnosed or received treatment for PE (premature ejaculation).
• Subjects with confirmed erectile dysfunction, hypo or hyperthyroidism, hypogonadism, hyperprolactinemia.
• Confirmed diagnosis of male subjects with other forms of ejaculatory dysfunction.
• Subjects that have had prior genital, prostatic or lower tract surgery.
• Subjects with haemorrhagic disorder, hepatitis B or C, HIV infection or having had penile implant surgery, at any time in their past.
• Either partner needed to use condoms for a specific STI protection.
• Subjects and their female partners who have any relevant history of allergy including local anaesthetics, parabens, PABA, commercial hair dyes, paraphenylenediamine, lubricants and latex.